Clinical Trials Logo

Filter by:
NCT ID: NCT04866615 Recruiting - Clinical trials for SLE (Systemic Lupus)

Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA

Start date: June 4, 2021
Phase:
Study type: Observational

Aim of The Study To evaluate different structural retinal changes using OCT and OCT-A in patients with SLE ; newly diagnosed patients and patients on treatment and compare parameters with normal subjects

NCT ID: NCT04863820 Recruiting - Clinical trials for Small Fiber Neuropathy

Small Fiber Assessment by Cutaneous Silent Period

Start date: April 27, 2021
Phase:
Study type: Observational

Our primary objective in this study is to investigate the cutaneous silent period (CSP) in normal subjects in the Egyptian population, as it was not carried out before in Egypt. The aim was to carry out the test in our unit to study the appropriate method, technique, and parameters of this new test so that we can apply it in future research. In addition, to obtain preliminary normative data of the test; onset latency, end latency, duration, and latency difference (LD) of CSP, as well as assess the effect of age, height, upper limb length, and gender on CSP values.

NCT ID: NCT04863144 Recruiting - Liver Diseases Clinical Trials

Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment

Start date: August 1, 2020
Phase:
Study type: Observational

The study aims to assess the pharmacokinetics of paclitaxel and its two major metabolites in patients with normal and impaired liver functions.

NCT ID: NCT04861168 Recruiting - Driving Pressure Clinical Trials

Driving Pressure Guided Ventilation Versus Conventional Lung Protective Strategy in Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

This study will be conducted to evaluate the effect of driving pressure guided ventilation compared with conventional protective lung ventilation during laparoscopic bariatric surgeries in morbid obese patients. - the primary outcome: Intraoperative oxygenation measured by the arterial partial pressure of oxygen (PaO2). - the secondary outcome: incidence of early postoperative pulmonary complications e.g., postoperative hypoxia, the need for supplementary oxygen, atelectasis, barotrauma, and respiratory failure.

NCT ID: NCT04860427 Recruiting - Clinical trials for Fracture of Condylar Process

Trapezoidal Condylar Plate (TCP) in Treatment of Subcondylar Fracture

Start date: June 10, 2019
Phase: N/A
Study type: Interventional

Background: Condylar fracture is a common mandibular fracture which accounts for 25-40%. Nowadays the preference started to change towards open reduction because of the late complications that might happen in case of closed treatment. A Transmasseteric Anteroparotid (TMAP) approach for open reduction and internal fixation of condylar fractures overcomes the problems of difficult access and facial nerve injury risk of other conventional approaches. Different plating options are available for internal fixation of the condyle and subcondylar region. Trapezoidal Condylar Plates (TCP) specifically developed for the osteosynthesis of low and high subcondylar fracture. These plates were designed to closely follow the tensile strain lines along the rim of the sigmoid notch anteriorly combined with a posterior arm to parallel the condylar axis free of harmful bending strains.

NCT ID: NCT04860245 Recruiting - Covid19 Clinical Trials

Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.

Start date: July 1, 2020
Phase:
Study type: Observational

The aim of this study is to assess risks and outcomes among COVID-19 patients admitted to Assiut University Hospitals.

NCT ID: NCT04860219 Recruiting - Covid19 Clinical Trials

Lactoferrin Use in (SARS-CoV-2) Management

SARS-CoV-2
Start date: July 8, 2020
Phase: N/A
Study type: Interventional

Background: Preventive, adjunctive and curative properties of lactoferrin have been evaluated since the first wave of severe acute respiratory syndrome coronavirus (SARS-CoV), viral respiratory disease, emerged 18 years ago. Despite the discovery of new vaccine candidates, there is currently no widely approved treatment for SARS-CoV-2 (COVID-19). Strict adherence to infection prevention and control procedures, as well as vaccines, can, however, prevent the spread of SARS-CoV-2. Objective: Hence, this study evaluated the efficacy of lactoferrin treatment in improving clinical symptoms and laboratory indices among individuals with mild to moderate coronavirus disease-19 (COVID-19). Design and Participants: A randomized, prospective, interventional pilot study conducted between July 8 and September 18, 2020 used a hospital-based sample of 54 laboratory confirmed participants with mild to moderate symptoms of COVID-19. Randomization into a control and two treatment groups ensured all groups received the approved Egyptian COVID-19 management protocol; only treatment group participants received lactoferrin at different doses for seven days. Clinical symptoms and laboratory indices were assessed on Days 0, 2 and 7 after starting treatments. Mean values with standard deviation and one-way analysis of variance with least significant difference post hoc of demographic and laboratory data between control and treatment groups were calculated. Key Results: Our study showed no stastically significant difference among studied groups regarding recovery of symptoms or laboratory improvement. Conclusion: Further research into therapeutic properties particularly related to dosage, duration and follow-up after treatment with lactoferrin in individuals with COVID-19 is required.

NCT ID: NCT04859049 Recruiting - Clinical trials for Pain Due to Certain Specified Procedures

Single Injection Infromedial Peribulbar Injection in Lacrimal Duct

Start date: September 10, 2021
Phase: N/A
Study type: Interventional

infromedial injection of 3 ml local anesthetic drugs and assessing the pain during lacrimal duct intubation and probability of false tracking

NCT ID: NCT04856722 Recruiting - Renal Stone Clinical Trials

Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones

Start date: April 5, 2021
Phase: N/A
Study type: Interventional

The optimal management of medium-sized renal stones remains quite challenging and continues to be contested. In the present study, the investigators will compare mini-PNL, RIRS and SWL in the treatment of non- lower pole, medium size, high dense renal stones regarding the stone-free rate, the safety of the procedures, cost, and patients' and surgeon's satisfaction. Eligible patients will be randomly allocated into three equal groups (mini-PNL, RIRS, and SWL). Postoperative, patients will be followed-up by regularly for 3 months. The study parameters will be compared between groups.

NCT ID: NCT04855110 Recruiting - Clinical trials for Maternal Complications After Oral Anticoagulation When Initiated Early and Late After Caesarean Section Done for Patients With Mechanical Heart Valve Prosthesis

Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis

Start date: April 19, 2021
Phase: N/A
Study type: Interventional

A randomized cohort study applied to patients with mechanical heart valve prosthesis who will be delivered by caesarean section at or after 28 weeks of gestation . Using a table of random numbers, participants will be divided into 2 equal groups. Group A (57 patients) in which warfarin will be started day 2 after caesarean delivery (i.e. 24 hours postoperative), and group B (57 patients) in which warfarin will be started day 5 after caesarean delivery, then maternal complications are compared among these 2 groups.